
See how Flowserve's latest guidance compares with that of peers facing similar order and execution risk by reviewing our curated list of list of solid balance sheet and fundamentals (24 results)
To own Flowserve, you need to be comfortable with a story built on margin work, aftermarket expansion and long cycle energy and power projects. The recent results serve as a reminder that the path is not smooth. Sales held up in the quarter, but earnings and profit margins softened, and the trimmed 2026 sales growth outlook shows the operating environment is tighter.
The key near term catalyst remains the execution of the Flowserve Business System and the mix shift toward higher margin aftermarket and nuclear related work. The biggest current risk sits in the Middle East. Management flagged delayed activity and revenue conversion in the region, which concentrates project timing risk in an already stressed geography.
The most relevant update is the 2026 earnings announcement on 28 October. Flowserve reported third quarter sales of US$1,237.77 million and net income of US$103.04 million, with basic EPS from continuing operations of US$0.81. For the first nine months, sales were US$3,475.22 million and net income was US$283.72 million, with EPS also lower than the prior year period.
Those figures sit alongside the reduced full year sales growth outlook of 2% to 3%, which management tied directly to Middle East disruptions that are delaying orders and pushing out revenue. For you as a shareholder, the link between this guidance revision and the existing risk list is clear. Execution on cost actions and margin initiatives now has to work harder to offset softer top line momentum.
Flowserve's current analyst narrative points to revenues of US$5.6b and earnings of US$837.9m by 2029, based on an assumed 6.3% yearly revenue growth rate, compared with earnings of US$254.7m today. This implies an earnings increase of about US$583m over that period.
Uncover why Flowserve's fair value indicates a 13% potential upside to its current price that may not last much longer.
One alternate view focuses on nuclear backlog risk. The most cautious Flowserve analysts already expected slower conversion, with revenue growth of about 6.1% a year and earnings of roughly US$815.9m by 2029. That is meaningfully below the consensus US$837.9m path. With fresh guidance cuts now in play, you can explore how those opinions might shift.
Explore 4 other Flowserve fair value estimates, including one that indicates there could be as much as 6% downside from the current price.
Don't just follow the ticker; dig into the data and build a conviction that's truly your own.
If this Flowserve review prompts you to widen your watchlist, the Simply Wall St Screener can help you quickly surface other opportunities that fit your risk and return preferences.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com